4C4I: Structure-Based Design Of Orally Bioavailable Pyrrolopyridine Inhibitors Of The Mitotic Kinase Mps1 reference: Structure-Based Design of Orally Bioavailable 1H-Pyrrolo[3,2-c]pyridine Inhibitors of Mitotic Kinase Monopolar Spindle 1 (MPS1)., Naud S, Westwood IM, Faisal A, Sheldrake P, Bavetsias V, Atrash B, Cheung KM, Liu M, Hayes A, Schmitt J, Wood A, Choi V, Boxall K, Mak G, Gurden M, Valenti M, de Haven Brandon A, Henley A, Baker R, McAndrew C, Matijssen B, Burke R, Hoelder S, Eccles SA, Raynaud FI, Linardopoulos S, van Montfort RL, Blagg J, J Med Chem. 2013 Dec 2. PMID: 24256217 |
This OCA
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).